This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Ajinomoto Co., Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Inventor Tatsuji Inomata and His Contributions to Cyclized Peptides
Introduction: Tatsuji Inomata is an innovative inventor based in Yokkaichi, Japan. With a focus on the realm of biochemistry, he has made significant strides in the production of cyclized peptides, particularly those featuring intramolecular S-S bonds. His ingenuity and expertise are reflected in a patent that contributes to advancements in peptide synthesis.
Latest Patents: Tatsuji Inomata holds one patent that details a "Method for producing cyclized peptide having intramolecular S-S bond." This patent encompasses techniques for preparing cyclized peptides with a crosslinked structure through one or more intramolecular S-S bonds, providing a valuable method for researchers and companies in the biopharmaceutical field.
Career Highlights: Currently, Tatsuji Inomata is affiliated with Ajinomoto Co., Ltd., a renowned company known for its contributions to food products and biotechnology. His work there emphasizes innovative methods in peptide synthesis, which are crucial in various medical and research applications.
Collaborations: Throughout his career, Tatsuji Inomata has worked alongside talented colleagues such as Daisuke Takahashi and Yuki Shinohara. Collaborative efforts among these professionals foster an environment of innovation, allowing for the exploration of new methodologies and the advancement of scientific knowledge.
Conclusion: Tatsuji Inomata exemplifies the spirit of innovation within the scientific community. His contributions to the field of cyclized peptides demonstrate the significant impact that dedicated inventors can have on technology and medicine. Through his work at Ajinomoto Co., Ltd. and his collaborations with esteemed colleagues, he continues to push the boundaries of current knowledge in biochemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
